@article {Castilla-Vallmanya406, author = {Laura Castilla-Vallmanya and M{\'o}nica Centeno-Pla and Mercedes Serrano and H{\'e}ctor Franco-Valls and Ra{\'u}l Mart{\'\i}nez-Cabrera and Aina Prat-Planas and Elena Rojano and Juan A G Ranea and Pedro Seoane and Clara Oliva and Abraham J Paredes-Fuentes and Gemma Marfany and Rafael Artuch and Daniel Grinberg and Raquel Rabionet and Susanna Balcells and Roser Urreizti}, title = {Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2}, volume = {60}, number = {4}, pages = {406--415}, year = {2023}, doi = {10.1136/jmg-2022-108690}, publisher = {BMJ Publishing Group Ltd}, abstract = {Background Schaaf-Yang syndrome (SYS) is caused by truncating mutations in MAGEL2, mapping to the Prader-Willi region (15q11-q13), with an observed phenotype partially overlapping that of Prader-Willi syndrome. MAGEL2 plays a role in retrograde transport and protein recycling regulation. Our aim is to contribute to the characterisation of SYS pathophysiology at clinical, genetic and molecular levels.Methods We performed an extensive phenotypic and mutational revision of previously reported patients with SYS. We analysed the secretion levels of amyloid-β 1{\textendash}40 peptide (Aβ1-40) and performed targeted metabolomic and transcriptomic profiles in fibroblasts of patients with SYS (n=7) compared with controls (n=11). We also transfected cell lines with vectors encoding wild-type (WT) or mutated MAGEL2 to assess stability and subcellular localisation of the truncated protein.Results Functional studies show significantly decreased levels of secreted Aβ1-40 and intracellular glutamine in SYS fibroblasts compared with WT. We also identified 132 differentially expressed genes, including non-coding RNAs (ncRNAs) such as HOTAIR, and many of them related to developmental processes and mitotic mechanisms. The truncated form of MAGEL2 displayed a stability similar to the WT but it was significantly switched to the nucleus, compared with a mainly cytoplasmic distribution of the WT MAGEL2. Based on the updated knowledge, we offer guidelines for the clinical management of patients with SYS.Conclusion A truncated MAGEL2 protein is stable and localises mainly in the nucleus, where it might exert a pathogenic neomorphic effect. Aβ1-40 secretion levels and HOTAIR mRNA levels might be promising biomarkers for SYS. Our findings may improve SYS understanding and clinical management.Data are available on reasonable request.}, issn = {0022-2593}, URL = {https://jmg.bmj.com/content/60/4/406}, eprint = {https://jmg.bmj.com/content/60/4/406.full.pdf}, journal = {Journal of Medical Genetics} }